Skip to main content
Sign In

Peter Forsberg, MD

Peter Forsberg, MD
University of Colorado School of Medicine
  • Assistant Professor of Medicine
  • Internal Medicine-Hematology and Oncology, Board Certification

Contact information​

Anschutz Medical Campus
12700 East 19th Ave
Research Complex 2, Campus Box B170
Aurora, CO  80045


Dr. Forsberg received his bachelor’s degree from Washington University in St. Louis.  He completed medical school at the University of Colorado School of Medicine.  He went to New York for his medical training and completed his residency in Internal Medicine at the Weill-Cornell Medical College/New York-Presbyterian Hospital.  He served as chief medical resident at Memorial Sloan Kettering Cancer Center before returning to Cornell for his fellowship training in Hematology and Medical Oncology.  In 2016 he returned to Colorado to join the blood cancer and BMT program at the University of Colorado.

Dr. Forsberg’s clinical and research focus centers on multiple myeloma and related diseases including amyloidosis and Waldenstrom’s Macroglobulinemia.  He serves as the principle investigator on various clinical trials.  He has published and presented his work at the national and international level.

  • ​​​​​​Washington University in St Louis, BA 2000-2004
  • University of Colorado School of Medicine, MD 2005-2009
  • New York-Presbyterian Hospital/Weill Cornell Medical College, Internal Medicine Residency, 2009-2012
  • Memorial Sloan Kettering Cancer Center, Chief Medical Resident, 2012-2013
  • New York-Presbyterian Hospital/Weill Cornell Medical College, Oncology Fellowship, 2013-2016

Dr. Forsberg’s research is focused on developing novel strategies to treat plasma cell disorders including multiple myeloma.  He works in collaboration with a group of clinical and laboratory based researchers to better characterize the biology of plasma cell diseases, understand the heterogeneity of these disorders in individual patients and develop personalized approaches to therapy in myeloma and related diseases. 

He is working to identify new therapeutic targets in multiple myeloma and to identify biomarkers to predict patient responses to different treatments.  He is also interested in evaluating and finding approaches to improve the quality of life in patients dealing with a group of diseases whose therapeutic landscape has evolved rapidly in the past several years.

Forsberg PA, Mark TM. Pomalidomide in the treatment of relapsed multiple myeloma. Future Oncology Jul 2013;9(7):939-48. 

Forsberg PA, Nikolova T(2014). Nonpain symptom management in AE Drilon & MA Postow(Eds.) Pocket Oncology Philadelphia, PA: Lippincot Williams & Wilkins, 103-105. 

Chapin J, Shore T, Forsberg P, Desman G, Van Besien K, Laurence J. Hematopoetic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. Clin Adv Hematol Oncol Sep 2014;12(9):565-73 

Forsberg P, DeSancho MT. Role of novel anticoagulants for patients with mechanical heart valves. Curr Athersclero Rep Nov 2014;16(11):448